Hospital News and Research

RSS

High Throughput Identification and Quantification of Breast Cancer With NMR-Based Metabolomics

Breast cancer is the leading cause of cancer-related death among the female population globally, despite the ever-growing technology of early detection.

From Bruker BioSpin Group 30 Oct 2020

Hospital floors create route of transfer of potentially dangerous organisms to patients

The floors of hospital rooms are quickly and frequently contaminated with antibiotic-resistant bacteria within hours of patient admission, creating a route of transfer of potentially dangerous organisms to patients, according to a study published today as part of the proceedings from Decennial 2020: The Sixth International Conference on Healthcare-Associated Infections.

30 Oct 2020

Researchers show how allergens are detected by the immune system

A key step in the immune system's response to allergens has been uncovered by researchers at Massachusetts General Hospital (MGH).

30 Oct 2020

Decision conflict may lead to less favorable treatment outcomes in cancer patients

Nearly one-third of cancer patients who decide to undergo surgery for their condition may have second thoughts, and this decision conflict may lead to less favorable treatment outcomes in both the near- and long-term, according to a team of investigators at Massachusetts General Hospital (MGH) and Ariadne Labs, a joint center for health systems innovation at the Harvard T.H. Chan School of Public Health and Brigham and Women's Hospital (BWH).

30 Oct 2020

Children with multiple islet autoantibodies are more likely to progress to type 1 diabetes

Children with multiple islet autoantibodies - biological markers of autoimmunity -- are more likely to progress to symptomatic type 1 diabetes (T1D) than those who remain positive for a single autoantibody.

30 Oct 2020

Study examines link between SARS-CoV-2 genomic load and COVID-19 patient outcomes

A new study published online in the Annals of the American Thoracic Society examines whether the amount of RNA, or genomic load, of SARS-CoV-2 detected in swab tests of patients being admitted to the hospital with viral pneumonia is associated with more severe COVID-19.

30 Oct 2020

SARS-CoV-2 spike proteins can directly impact the blood-brain barrier

Like a key, SARS-CoV-2 - the virus that causes coronavirus disease 2019 (COVID-19) - attaches to specific molecules on the host cell surface, opening gateways into the cell interior.

30 Oct 2020

Research shows some COVID-19 patients experience long-lasting skin symptoms

Some COVID-19 patients experience long-lasting skin symptoms that vary according to type of COVID-19 skin rash, a late-breaking abstract will reveal today at the 29th EADV Congress, EADV Virtual.

30 Oct 2020

Scientists develop new model of coronavirus diffusion through a community

The coronavirus doesn't spread uniformly through a community.But in the world of disease modeling, many projections take a high-level approach to a geographic area, like a county or state, and forecast based on a general idea that a virus will take root and spread at an equal rate until it reaches its peak of infection.

30 Oct 2020

Seroprevalence and immune response to SARS-CoV-2 in Paris

François Anna et al. published this study in a recent medRxiv* preprint paper, where they present the results of assessing the serological response in the selected population. They tested for specific IgG response against the SARS CoV-2 Nucleoprotein and Spike protein and performed a pseudo-neutralization assay in sera of urban dwellers in Paris.

30 Oct 2020

Research projects receive BTCA grants to develop novel drugs for various diseases

Five research projects with exceptional promise to deliver new life-changing and health-altering therapies have received the inaugural Blavatnik Therapeutics Challenge Awards (BTCA) at Harvard Medical School.

30 Oct 2020

COVID-19 study: Researchers recruit frontline workers to identify asymptomatic individuals

Fifteen hundred frontline workers are being recruited for a yearlong study to find what percentage are positive for the virus that causes COVID-19, what percentage become positive and whether the antibodies they produce protect them from reinfection.

30 Oct 2020

Massey Cancer Center and VCUarts win Hamilton International Arts in Health Award

Last year, 12 patients in the Supportive Care Clinic at VCU Massey Cancer Center stepped inside a conference room, donned motion sensors and engaged in a facilitated life review, acting out various parts of their lives through a virtual avatar displayed on a projection screen.

30 Oct 2020

Study sheds new light on the biological base of psychotic symptoms

Anti-NMDAR encephalitis is an autoimmune brain illness that is often mistaken by a psychiatric disorder since it causes psychoses and other behaviour alterations. Despite having these similarities, the illness does not respond to common antipsychotic treatments.

30 Oct 2020

A2B-COVID: Rapid identification of SARS-CoV-2 transmission

A new study published on the preprint server medRxiv in October 2020 reports a method to assess transmission potential for any event in the current pandemic, using what is known about the virus's spread, data on the mobility of individuals, and new ways of processing genomic sequencing data. The outcome is to determine whether cases are linked or not so as to take action to prevent further spread.

29 Oct 2020

COVID-19 patients at risk of fatal co-infection during ICU stays

Researchers in the UK have conducted a study showing that a high proportion of patients admitted to intensive care units (ICU) with coronavirus disease 2019 (COVID-19) acquire a secondary bacterial co-infection during their hospital stay.

29 Oct 2020

App-based surveillance system enables early detection of COVID-19 hotspots

Researchers in the UK, United States, and Sweden have used large-scale self-reported app data to estimate coronavirus disease 2019 (COVID-19) incidence, prevalence, and effective reproductive number in England.

29 Oct 2020

UH and CWRU announce Phase 3 trial of Astrazeneca's investigational COVID-19 vaccine

University Hospitals and Case Western Reserve University announced today that UH Cleveland Medical Center has been selected as a clinical trial site for the Phase 3 global study of an investigational vaccine against SARS-CoV-2, sponsored by AstraZeneca.

29 Oct 2020

Study sheds light on the biological base of symptoms in autoimmune psychosis

29 Oct 2020

Study suggests a role for the hypothalamus in genetic susceptibility to IBD

Using sophisticated 3D genomic mapping and integrating with public data resulting from genome-wide association studies, researchers at Children's Hospital of Philadelphia have found significant genetic correlations between inflammatory bowel disease and stress and depression.

29 Oct 2020

Hospital News and Research

High Throughput Identification and Quantification of Breast Cancer With NMR-Based Metabolomics

Hospital floors create route of transfer of potentially dangerous organisms to patients

Researchers show how allergens are detected by the immune system

Decision conflict may lead to less favorable treatment outcomes in cancer patients

Children with multiple islet autoantibodies are more likely to progress to type 1 diabetes

Study examines link between SARS-CoV-2 genomic load and COVID-19 patient outcomes

SARS-CoV-2 spike proteins can directly impact the blood-brain barrier

Research shows some COVID-19 patients experience long-lasting skin symptoms

Scientists develop new model of coronavirus diffusion through a community

Seroprevalence and immune response to SARS-CoV-2 in Paris

Research projects receive BTCA grants to develop novel drugs for various diseases

COVID-19 study: Researchers recruit frontline workers to identify asymptomatic individuals

Massey Cancer Center and VCUarts win Hamilton International Arts in Health Award

Study sheds new light on the biological base of psychotic symptoms

A2B-COVID: Rapid identification of SARS-CoV-2 transmission

COVID-19 patients at risk of fatal co-infection during ICU stays

App-based surveillance system enables early detection of COVID-19 hotspots

UH and CWRU announce Phase 3 trial of Astrazeneca's investigational COVID-19 vaccine

Study sheds light on the biological base of symptoms in autoimmune psychosis

Study suggests a role for the hypothalamus in genetic susceptibility to IBD

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Latest News